Bioscience Evidence 2024, Vol.14, No.5, 227-237 http://bioscipublisher.com/index.php/be 234 8 Future Directions 8.1 Emerging technologies in ASFV drug target identification The identification of drug targets for African Swine Fever Virus (ASFV) has significantly advanced with the advent of high-throughput proteomic and genomic technologies. Techniques such as affinity purification coupled with mass spectrometry have been instrumental in elucidating the interactome of ASFV proteins, revealing critical interactions with host cellular machinery. For instance, the identification of Rab proteins as key interactors of ASFV proteins P34 and E199L highlights the importance of the endocytic pathway in ASFV infection, suggesting potential therapeutic targets (García-Dorival et al., 2023). Additionally, the comprehensive mapping of virus-host and virus-virus protein interactions provides a systematic overview of the ASFV interactome, identifying crucial molecular mechanisms and potential antiviral targets (Dolata et al., 2023). These emerging technologies not only enhance our understanding of ASFV biology but also pave the way for the development of novel antiviral strategies. 8.2 Prospects of personalized medicine in treating ASFV Personalized medicine, which tailors treatment based on individual genetic and proteomic profiles, holds promise for ASFV treatment. The integration of proteomic data with genomic information can identify specific biomarkers and therapeutic targets unique to different ASFV strains or host responses. For example, the identification of conserved epitopes in ASFV proteins, such as the CD2v protein, can inform the development of targeted vaccines and diagnostic tools (Liu et al., 2022). Moreover, the use of monoclonal antibodies against specific ASFV proteins, like p54, demonstrates the potential for personalized therapeutic approaches that can enhance the efficacy of treatment and control measures (Petrovan et al., 2020). As our understanding of ASFV-host interactions deepens, personalized medicine approaches could significantly improve the management and outcome of ASFV infections. 8.3 Importance of continued research in ASFV genomics and proteomics Continued research in ASFV genomics and proteomics is crucial for the ongoing battle against this devastating virus. The dynamic nature of ASFV and its ability to evade host immune responses necessitate a thorough understanding of its genetic and proteomic landscape. Studies focusing on the modulation of host antiviral innate immunity by ASFV proteins provide insights into potential vaccine targets and antiviral drugs (He et al., 2022). Furthermore, the identification of novel therapeutic targets through proteomic analyses underscores the importance of sustained research efforts (Henry et al., 2022). By expanding our knowledge of ASFV genomics and proteomics, we can develop more effective diagnostic tools, vaccines, and treatments, ultimately leading to better control and eradication of African Swine Fever. 9 Concluding Remarks Recent genomic and proteomic studies have significantly advanced our understanding of African Swine Fever Virus (ASFV) and its potential as a target for therapeutic intervention. High-throughput proteomic analyses have elucidated the interactome of several ASFV proteins, identifying critical molecular pathways involved in the virus's life cycle, such as intracellular and Golgi vesicle transport, endoplasmic reticulum organization, lipid biosynthesis, and cholesterol metabolism. Additionally, bioinformatics analysis has revealed numerous G-Quadruplex-forming sequences within the ASFV genome, which can be stabilized by specific ligands, thereby inhibiting viral replication. These findings underscore the importance of targeting viral proteins and genomic structures to develop effective antiviral strategies. The identification of ASFV proteins and genomic structures as drug targets holds significant promise for the development of novel antiviral therapies. For instance, the discovery of Rab proteins as crucial regulators of the endocytic pathway necessary for ASFV infection suggests that targeting these proteins could disrupt the virus's ability to enter and exit host cells. Furthermore, the stabilization of G-Quadruplexes in the ASFV genome by ligands such as N-Methyl Mesoporphyrin and pyridostatin has demonstrated potential in inhibiting viral replication in vitro. These targeted approaches could lead to the development of broad-spectrum antiviral compounds that are effective against ASFV and other pathogenic viruses.
RkJQdWJsaXNoZXIy MjQ4ODYzMg==